← All stocks

Cellectar Biosciences, Inc.

CLRB Net buying
CIK 0001279704 #4979 in the set updated 20 Sep 2026
Bought (120 mo)
$962.54K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$109.43K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$109.43K
7 of 7 sales
Net
+$853.11K
+$853.11K against sales at will

By person

12 insiders · 27 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
NEIS JOHN
Director
$496.67K (1)
$8.52K (2)
+$488.14K
626,113
$1.80M
+110.0%
Longcor Jarrod
Chief Operating Officer
$199.53K (7)
$15.40K (1)
+$184.13K
20,451
$58.90K
CARUSO JAMES V
President & CEO
$160.73K (6)
$40.70K (1)
+$120.03K
20,318
$58.52K
Hertzberg Richard
significant owner
$42.61K (1)
−$42.61K
280,000
$806.40K
−7.0%
Swirsky Douglas J
Director
$26.00K (1)
+$26.00K
25,000
$72.00K
Kolean Chad J
CFO
$24.95K (1)
+$24.95K
6,418
$18.48K
DRISCOLL FREDERICK W
Director
$20.24K (1)
+$20.24K
19,417
$55.92K
HILL STEPHEN A
Director
$19.44K (1)
$2.19K (2)
+$17.25K
18,000
$51.84K
+1,715%
Elefant Dov
Chief Financial Officer
$14.98K (2)
+$14.98K
11,755
$33.85K
Friend John E. II
Chief Medical Officer
100,000
$288.00K
Shustov Andrei
Senior Vice President, Medical
55,038
$158.51K
+666.4%
Lea Darrell Shane
Chief Commercial Officer
39,599
$114.05K

No percentages here. This company's share count has moved by a factor of 14.4 over the window, from 3,192,040 to 46,079,875 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 126
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 823,532
Sales filed before the plan box existed 6
History held since 1 Nov 2016